Matt Danilo
About Matt Danilo
Matt Danilo serves as the Director of Enterprise Development at Abridge, where he focuses on integrating AI technology with healthcare systems. He has extensive experience in customer success and growth roles at CipherHealth and has a background in health policy and business law from Penn State University.
Current Role at Abridge
Matt Danilo serves as the Director of Enterprise Development at Abridge since 2023. In this role, he focuses on enhancing enterprise-grade technology solutions that integrate with electronic medical records (EMR) systems. His work aims to improve the efficiency of clinical documentation and optimize patient-clinician interactions through advanced technology.
Previous Experience at CipherHealth
Prior to his current position, Matt Danilo held multiple roles at CipherHealth. He began as a Customer Success Manager in 2016, where he worked for three months. He then progressed to Senior Customer Success Manager from 2016 to 2018, followed by the role of Vice President, Growth from 2018 to 2023. During his tenure, he contributed to the company's growth and customer success initiatives in the Greater New York City Area and New York City Metropolitan Area.
Consulting Background at FTI Consulting
Before joining CipherHealth, Matt Danilo worked at FTI Consulting as a Consultant in Health Solutions from 2013 to 2016. His experience in this role involved providing strategic consulting services within the healthcare sector, focusing on improving operational efficiencies and client outcomes in the New York City Metropolitan Area.
Education and Expertise
Matt Danilo earned a Bachelor of Science degree in Health Policy & Business Law from Penn State University, where he studied from 2009 to 2013. His educational background supports his expertise in leveraging AI-powered platforms to enhance clinical documentation efficiencies and advocating for the responsible deployment of AI in healthcare.
Contributions to Healthcare Standards
Matt Danilo actively contributes to setting industry standards for generative AI in healthcare. His advocacy focuses on improving patient-clinician interactions through technology, emphasizing the importance of responsible AI deployment in the healthcare sector.